DrugPatentWatch Database Preview
Mechanism of Action: Radiopharmaceutical Activity
Join the DrugPatentWatch Referral Program Get access to a free drug patent landscape report or a free one-month subscription
Drugs with Mechanism of Action: Radiopharmaceutical Activity
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Curium | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 018327-001 | Mar 9, 1982 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
Lantheus Medcl | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 017284-001 | Approved Prior to Jan 1, 1982 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
Curium | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 018327-002 | Mar 9, 1982 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
Lantheus Medcl | XENON XE 133 | xenon xe-133 | GAS;INHALATION | 017284-002 | Approved Prior to Jan 1, 1982 | RX | No | No | Start Trial | Start Trial | Start Trial | ||||
Ge Healthcare | VIZAMYL | flutemetamol f-18 | INJECTABLE;INTRAVENOUS | 203137-001 | Oct 25, 2013 | DISCN | Yes | No | Start Trial | Start Trial | Y | Start Trial | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |